Quest Laboratories (NSE:QUESTLAB) Accounts Receivable: ₹362.1 Mil (As of Mar. 2026)


NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
52 GF Score
Price ₹94.95
! 7 Warning Signs
View Full Analysis

What is Quest Laboratories Accounts Receivable?

Quest Laboratories NSE:QUESTLAB +1.28% 52 Accounts Receivable is ₹362.1 Mil as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 52/100. The stock has 7 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Quest Laboratories's accounts receivables for the quarter that ended in Mar. 2026 was ₹362.1 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Quest Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2026 was 101.98.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Quest Laboratories's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹27.49.


Quest Laboratories Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Quest Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=362.144/324.046*91
=101.98

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Quest Laboratories's accounts receivable are only considered to be worth 75% of book value:

Quest Laboratories's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(132.13+0.75 * 362.144+0.5 * 386.195-143.285
-0-0)/16.497
=27.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Quest Laboratories Accounts Receivable Related Terms


Quest Laboratories Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories Accounts Receivable Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Receivable
Get a 7-Day Free Trial 220.62 212.33 244.43 300.32 362.14

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 244.43 0.00 300.32 301.08 362.14
NSE:QUESTLAB
52GF Score
Quest Laboratories Ltd NSE:QUESTLAB
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of ₹362.1 Mil mean?
Quest Laboratories (NSE:QUESTLAB) has a Accounts Receivable of ₹362.1 Mil as of Mar. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Quest Laboratories and its competitors.
Is Quest Laboratories' Accounts Receivable too high?
Quest Laboratories' current Accounts Receivable is ₹362.1 Mil. Overall, Quest Laboratories has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Accounts Receivable compare to LLY and JNJ?
Quest Laboratories' Accounts Receivable of ₹362.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Drug Manufacturers company?
A good Accounts Receivable depends on the Drug Manufacturers industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Quest Laboratories and its competitors. Quest Laboratories's current Accounts Receivable is ₹362.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Accounts Receivable of ₹362.1 Mil. The current Accounts Receivable is ₹362.1 Mil. Quest Laboratories' overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Accounts Receivable is ₹362.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
52GF Score

Get the complete analysis for NSE:QUESTLAB

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹94.95
Price